• Explore /
  • Poster
  • / The role of previous radical local treatment (RLT) on the outcome of immune checkpoint inhibitors (ICI) in patients (pts) with metastatic urothelial carcinoma (mUC).

The role of previous radical local treatment (RLT) on the outcome of immune checkpoint inhibitors (ICI) in patients (pts) with metastatic urothelial carcinoma (mUC).

Abstract Poster

Authors

Rafael Morales-Barrera, Sr

Rafael Morales-Barrera

Vall d'Hebron Institute, Barcelona, Spain

Rafael Morales-Barrera , Natalia Vidal Casinello , Montserrat Domenech , Teresa Bonfill , Javier Puente , Mariona Figols , Julia Giner Joaquin Jr., Macarena Gonzalez , Fernando Lozano , Hector Lopez , Isabel Galante , Richard Mast , Ester Serra Hernandez , Maria Eugenia Semidey , Cesar Serrano , Enrique Gallardo Diaz , Cristina Suarez Rodriguez , Xavier Maldonado , Juan Morote , Joan Carles

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 496)

Abstract #

496

Poster Bd #

H19

Abstract Disclosures

Similar Posters

First Author: Thierry Landre

First Author: Alex K. Bryant

First Author: Benjamin Miron

First Author: Rafael Morales-Barrera